| Literature DB >> 26529606 |
Peng Yin1, Qiunan Ji2, Tongtong Li1, Jiantao Li3, Zhirui Li3, Jianheng Liu3, Guoqi Wang3, Song Wang1, Lihai Zhang3, Zhi Mao3, Peifu Tang3.
Abstract
BACKGROUND: Infected nonunion of tibia and femur are common in clinical practice, however, the treatment of these diseases has still been a challenge for orthopaedic surgeons. Ilizarov methods can eradicate infection, compensate bone defects and promote the bone union through progressive bone histogenesis. The objective of this systematic review was to review current available studies reporting on Ilizarov methods in the treatment of infected nonunion of tibia and femur, and to perform meta-analysis of bone and functional results and complications to evaluate the efficacy of Ilizarov methods.Entities:
Mesh:
Year: 2015 PMID: 26529606 PMCID: PMC4631548 DOI: 10.1371/journal.pone.0141973
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Flow chart illustrating number of studies evaluated at each stage in the systematic review.
Characteristics of included studies.
| Author | Study No. | Year | Study design | Number of patients | Mean age (years) | MPSP (per patient) | Mean bone defects(cm) | Follow-up (months) |
|---|---|---|---|---|---|---|---|---|
| Yin1 | 1 | 2015 | RS | 72 | 38.45 | 2.55 | 6.46 | 24.13 |
| Khan10 | 2 | 2015 | RS | 24 | 38 | 2 | 3.3 | 11 |
| Peng17 | 3 | 2015 | RS | 58 | 29.4 | 6.3 | 9.2 | 31.6 |
| Xu18 | 4 | 2014 | RS | 30 | 34.1 | 6 | 6.43 | 29 |
| Feng19 | 5 | 2013 | RS | 21 | 34.6 | 6 | 6.6 | 31 |
| Blum13 | 6 | 2010 | RS | 50 | 29.9 | 3.8 | 8.8 | 70.8 |
| Megas20 | 7 | 2010 | RS | 9 | 39.7 | 4.8 | 5 | 26.6 |
| Bumbasirevic4 | 8 | 2010 | RS | 30 | 30.4 | 1.3 | 6.9 | 99 |
| Emara22 | 9 | 2008 | RC | 33 | 29 | __ | 6 | 36 |
| Madhusudhan7 | 10 | 2008 | PC | 22 | 37.2 | 3 | 4/5.4 | 13 |
| Rose12 | 11 | 2007 | RS | 6 | 31.83 | 3.83 | 4.33 | 7.6 |
| Magadum24 | 12 | 2006 | RS | 27 | 39 | 2 | 10 | 27 |
| Krishnan14 | 13 | 2006 | RS | 20 | 38.4 | 4.4 | 6 | 63 |
| Saridis23 | 14 | 2006 | RS | 13 | 34.6 | 3 | 8.3 | 42.4 |
| Abdel-Aal25 | 15 | 2006 | RS | 9 | 30.66 | __ | 10.7 | __ |
| McHale26 | 16 | 2004 | RS | 10 | 31 | __ | __ | 36 |
| Arora27 | 17 | 2003 | RS | 46 | 35 | 2.1 | 6 | 67 |
| Atesalp28 | 18 | 2002 | RS | 14 | 25 | __ | 4.4 | 33.2 |
| Barbarossa15 | 19 | 2001 | RS | 23 | 40.7 | 4.2 | 6.2 | __ |
| Maini29 | 20 | 2000 | RS | 15 | 27.4 | 2.5 | 7 | 31.2 |
| Laursen30 | 21 | 2000 | RS | 9 | 25.78 | 6.9 | 4.89 | 39.4 |
| Ring11 | 22 | 1999 | RS | 10 | 34 | __ | 4.3 | 7.2 |
| Hosny8 | 23 | 1998 | RS | 11 | 27 | 2 | 3.7 | 13 |
| Dendrinos31 | 24 | 1995 | RS | 28 | 37 | 4 | 6 | 39 |
| Total number of patients | 590 |
MPSP mean previous surgical procedures RS retrospective case series RC retrospective comparative study
PC prospective comparative study
__ The data did not be reported in studies.
* The study included two groups, the mean bone defects is 4cm in one group, and 5.4cm in another group.
Interventions and Outcomes of included studies.
| Study No. | Technique | Site | Bone union No.(%) | Bone results(ASAMI) (excellent/good/fair/poor) | Functional results(ASAMI) (excellent/good/fair/poor) | Complications (per patient) | EFT (months) | EFI (Ms/cm) |
|---|---|---|---|---|---|---|---|---|
| 1 | RD,AT,BT(IEF) | 72T | 72/72(100%) | 46/17/7/2 | 25/27/13/0 | 1.10(79/72) | 9.56 | 1.48 |
| 2 | RD,AT,BT or CO (IEF) | 24T | 22/23(95.7%) | 6/14/1/2 | 8/12/2/0(1 failure) | 0.5(12/24) | 8 | 4.2 |
| 3 | RD,AT,BT(IEF) | 58T | 58/58(100%) | 30/23/5/0 | 28/18/12/0 | 0.67(39/58) | 10.6 | 1.2 |
| 4 | RD,AT,BT(IEF) | 30 T | 30/30(100%) | 28/2/0/0 | __ | 0.27(8/30) | 10 | 1.37 |
| 5 | RD,AT,BT(IEF) | 21 T | 21/21(100%) | 19/2/0/0 | __ | 0.4(8/21) | 9.8 | 1.48 |
| 6 | RD,AT,BT(IEF) | 50 F | 49/50(98%) | __ | __ | 2.1(105/50) | 24.5 | 2.8 |
| 7 | RD,AT,CO or ACL(IEF) | 9 T | 9/9(100%) | 5/4/0/0 | 3/4/2/0 | 1.89(17/9) | 7.83 | 1.07 |
| 8 | RD,AT,BT(IEF) | 30 T | 29/30(97%) | 19/10/0/1 | 13/14/2/1 | 1.4(42/30) | 9.7 | 1.48 |
| 9 | RD,AT, BT(IEF),BG | 16 T | 16/16(100%) | 15/1/0/0 | 12/1/3/0 | 0.4(6/16) | 8.5 | 1.5 |
| RD,AT, BT(IEF and IMN),BG | 17T | 17/17(100%) | 17/0/0/0 | 13/2/2/0 | 0.12(2/17) | 3.1 | 0.55 | |
| 10 | RD, AT,ACL(IEF) | 13 T | 13/13(100%) | 4/3/4/2 | 1/3/6/2 | 2.73(60/22) | 9.3 | 2.33 |
| RD, AT,BT(IEF) | 9 T | 9/9(100%) | 0/3/4/2 | 0/1/3/2 | 8.5 | 1.57 | ||
| 11 | RD,AT,CO or BT(IEF) | 5 T/1 F | 5/6(83.3%) | 1/3/1/1 | 1/3/0/2 | 1.33(8/6) | 10 | __ |
| (5T+1F) | (5T+1F) | |||||||
| 12 | RD, ACL(IEF) | 27 T | 24/25(96%) | 19/5/0/1 | 15/8/1/1 | 1.16(29/25) | 10.2 | 1.02 |
| 13 | RD,AT,BT or ACL(IEF) | 20 F | 19/20(95%) | 13/4/1/1(1AMP) | 3/9/3/4(1AMP) | 3.55(71/20) | 7.8 | 1.28 |
| 14 | RD,AT,ACL or BT(IEF) | 13 F | 13/13(100%) | 8/4/1/0 | 3/4/4/2 | 0.76(10/13) | 10.33 | 1.24 |
| 15 | RD,BT(IEF) | 9 T | 9/9(100%) | __ | __ | 1.11(10/9) | 12.78 | 1.22 |
| 16 | RD,AT,BT or ACL or CO(IEF) | 10 T | 10/10(100%) | __ | __ | 0.4(4/10) | 9.0 | __ |
| 17 | RD,BT or CO(IEF) | 38 T/8 F | 44/46(95.4%) | __ | 15/16/13/2 | 0.74(34/46) | 8.7 | 1.33 |
| 18 | RD,AT,3 flaps, BT(IEF) | 14 T | 13/14(92.9%) | __ | __ | 1.21(17/14) | 6.8 | 1.55 |
| 19 | RD,AT,BT(IEF) | 23 T | 20/23(87%) | 8/8/2/4(1AMP) | 2/10/6/4(1AMP) | 3.39(78/23) | __ | __ |
| 20 | RD,AT,BT(IEF) | 3 F/12 T | 15/15(100%) | 7/3/0/5 | 4/7/1/3 | 2.27(34/15) | __ | __ |
| 21 | RD,AT,CO or BT(IEF) | 9 T | 9/9(100%) | __ | __ | 1.56(14/9) | 6.7 | __ |
| 22 | RD,3flaps,BT or ACL or CO(IEF) | 10 T | 9/10(90%) | __ | __ | 2.5(25/10) | 6.9 | __ |
| 23 | RD,3AT, BT or CO(IEF) | 11 T | 11/11(100%) | __ | 5/3/2/1 | 1.27(14/11) | 8.5 | 2.3 |
| 24 | RD,BT(IEF) | 28 T | 25/28(89%) | 14/8/1/5 | 7/11/4/5(1AMP) | 2.5(71/28) | 10 | 1.67 |
# 1 patient die for advanced liver disease
* 7 patient lost for follow up
**3 patients were unable to evaluate
***Complications did not be recorded separately by groups
****2 patients lost for follow up
__ The data did not be reported in studies.
ACL acute compression and lengthening AMP amputation ASAMI Association for the Study of the Method of Ilizarov AT antibiotics treatment BG bone graft BT bone transport CO compression osteosynthesis EFI external fixation index EFT external fixation time F femur IEF Ilizarov external fixator IMN intramedullary nailing Ms/cm months/cm RD radical debridement T tibia
Meta-analysis of bone results and functional results evaluated by ASAMI.
| Results | Relevant studies (n) | Heterogeneity(I2,%; P) | ES(95% CI) | Range of incidence (%) |
|---|---|---|---|---|
|
| ||||
| Rate of excellent results | 16[
| I2 = 93.1; P = 0.000 | 0.58 (0.44,0.72) | 17–97 |
| Rate of good results | 16[
| I2 = 80.8; P = 0.000 | 0.26 (0.18,0.34) | 3–61 |
| Rate of fair results | 9[
| I2 = 26.9; P = 0.205 | 0.08 (0.04,0.12) | 4–36 |
| Rate of poor results | 10[
| I2 = 44.1; P = 0.065 | 0.08 (0.04,0.12) | 3–33 |
|
| ||||
| Rate of excellent results | 16[
| I2 = 84.8; P = 0.000 | 0.33 (0.23,0.44) | 6–76 |
| Rate of good results | 16[
| I2 = 59.3; P = 0.001 | 0.36 (0.28,0.43) | 9–52 |
| Rate of fair results | 15[
| I2 = 56.4; P = 0.004 | 0.17 (0.11,0.22) | 4–50 |
| Rate of poor results | 11[
| I2 = 34.7; P = 0.121 | 0.10 (0.05,0.14) | 3–33 |
Subgroup analysis of bone results and functional results evaluated by ASAMI based on the sites of infected nonunion.
| Results | Relevant studies (n) | Heterogeneity(I2,%; P) | ES(95% CI) | Range of incidence (%) |
|---|---|---|---|---|
|
| ||||
|
| ||||
| Rate of excellent results | 12[
| I2 = 94.4; P = 0.000 | 0.61 (0.45,0.77) | 18–97 |
| Rate of good results | 12[
| I2 = 85.2; P = 0.000 | 0.26 (0.16,0.36) | 3–61 |
| Rate of fair results | 6[
| I2 = 51.5; P = 0.067 | 0.09 (0.03,0.14) | 4–36 |
| Rate of poor results | 7[
| I2 = 40.8; P = 0.119 | 0.07 (0.02,0.11) | 3–18 |
|
| ||||
| Rate of excellent results | 11[
| I2 = 89.2; P = 0.000 | 0.38 (0.23,0.52) | 6–76 |
| Rate of good results | 11[
| I2 = 69.7; P = 0.000 | 0.34 (0.25, 0.44) | 9–52 |
| Rate of fair results | 11[
| I2 = 59.1; P = 0.007 | 0.16 (0.10,0.22) | 4–50 |
| Rate of poor results | 6[
| I2 = 40.0; P = 0.139 | 0.09 (0.03,0.15) | 3–22 |
|
| ||||
|
| ||||
| Rate of excellent results | 2[
| I2 = 0; P = 0.839 | 0.64 (0.47,0.80) | 61–65 |
| Rate of good results | 2[
| I2 = 0; P = 0.489 | 0.24 (0.09,0.38) | 20–31 |
| Rate of fair results | 2[
| I2 = 0; P = 0.760 | 0.06 (-0.02,0.14) | 5–8 |
| Rate of poor results | 1[
| _ | 0.05 (-0.05,0.15) | 5 |
|
| ||||
| Rate of excellent results | 2[
| I2 = 0; P = 0.567 | 0.18 (0.05,0.30) | 15–23 |
| Rate of good results | 2[
| I2 = 0; P = 0.402 | 0.39 (0.22,0.55) | 31–45 |
| Rate of fair results | 2[
| I2 = 8.8; P = 0.295 | 0.20 (0.06,0.34) | 15–31 |
| Rate of poor results | 2[
| I2 = 0; P = 0.732 | 0.18 (0.05,0.31) | 15–20 |
Meta-analysis of complications of infected nonunion of tibia and femur treated by Ilizarov methods.
| Complications | Relevant studies (n) | Heterogeneity(I2,%; P) | ES(95% CI) | Range of incidence (%) |
|---|---|---|---|---|
| Pin-track infection | 23[
| I2 = 97.6; P = 0.000 | 0.56 (0.43,0.69) | 10–100 |
| Axial deviation | 6[
| I2 = 76.5; P = 0.001 | 0.40 (0.25,0.56) | 22–70 |
| Bone grafting | 5[
| I2 = 56.4; P = 0.057 | 0.20 (0.09,0.31) | 10–30 |
| Loosening of wires | 9[
| I2 = 64.7; P = 0.004 | 0.15 (0.08,0.22) | 6–48 |
| Breakage of wires | 5[
| I2 = 57.1; P = 0.054 | 0.05 (0.00,0.09) | 2–32 |
| Knee stiffness | 4[
| I2 = 1.6; P = 0.384 | 0.12 (0.05,0.19) | 9–30 |
| Ankle stiffness | 4[
| I2 = 64.9; P = 0.036 | 0.31 (0.11,0.52) | 13–56 |
| Malunion | 8[
| I2 = 0; P = 0.570 | 0.07 (0.03,0.11) | 4–22 |
| Refracture | 9[
| I2 = 0; P = 0.931 | 0.04 (0.02,0.07) | 3–13 |
| Infectious recurrence | 7[
| I2 = 24.2; P = 0.245 | 0.05 (0.01,0.10) | 2–30 |
| Limb edema | 3[
| I2 = 0; P = 0.890 | 0.13 (0.04,0.21) | 9–14 |
| Amputation | 4[
| I2 = 0; P = 0.936 | 0.04 (0.00,0.09) | 4–10 |
| Peroneal nerve palsy | 2[
| I2 = 0; P = 0.585 | 0.13 (-0.01,0.28) | 10–18 |
Subgroup analysis of complications based on the sites of infected nonunion.
| Complications | Relevant studies (n) | Heterogeneity(I2,%; P) | ES(95% CI) | Range of incidence (%) |
|---|---|---|---|---|
|
| ||||
| Pin-track infection | 17[
| I2 = 97.2; P = 0.000 | 0.48 (0.29,0.68) | 10–100 |
| Axial deviation | 4[
| I2 = 62.3; P = 0.047 | 0.38 (0.23,0.53) | 22–52 |
| Bone grafting | 3[
| I2 = 19.6; P = 0.288 | 0.14 (0.03,0.24) | 10–30 |
| Loosening of wires | 6[
| I2 = 73.8; P = 0.002 | 0.17 (0.05,0.28) | 6–48 |
| Breakage of wires | 4[
| I2 = 67.2; P = 0.028 | 0.06 (-0.01,0.12) | 2–32 |
| Knee stiffness | 3[
| I2 = 15.5; P = 0.306 | 0.13 (0.03,0.22) | 9–30 |
| Ankle stiffness | 3[
| I2 = 62.8; P = 0.068 | 0.26 (0.04,0.49) | 13–56 |
| Malunion | 8[
| I2 = 0; P = 0.570 | 0.07 (0.03,0.11) | 4–22 |
| Refracture | 6[
| I2 = 0; P = 0.885 | 0.04 (0.01,0.07) | 3–11 |
| Infectious recurrence | 6[
| I2 = 34.5; P = 0.178 | 0.06 (0.00,0.11) | 2–30 |
| Limb edema | 3[
| I2 = 0; P = 0.890 | 0.13 (0.04,0.21) | 9–14 |
| Amputation | 3[
| I2 = 0; P = 0.817 | 0.04 (-0.01,0.09) | 4–10 |
| Peroneal nerve palsy | 2[ | I2 = 0; P = 0.585 | 0.13 (-0.01,0.28) | 10–18 |
|
| ||||
| Pin-track infection | 3[
| I2 = 90.3; P = 0.000 | 0.77 (0.45,1.09) | 55–100 |
| Axial deviation | 1[
| _ | 0.70 (0.50,0.90) | 70 |
| Bone grafting | 1[
| _ | 0.30 (0.17,0.43) | 30 |
| Loosening of wires | 1[
| _ | 0.08 (0.00,0.16) | 8 |
| Breakage of wires | 1[
| _ | 0.04 (-0.02,0.10) | 4 |
| Refracture | 2[
| I2 = 0; P = 0.761 | 0.06 (-0.02,0.14) | 5–8 |
| Amputation | 1[
| _ | 0.05 (-0.05,0.15) | 5 |